http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2288226-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2002-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09a40a1268be83253858aed33e84dd46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bffd0f62e06892a8ab349294c8d2468e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf8ec6bf4d65289541b5ebd9516129f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7c65a5502a09b7f18c15b96981333ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff70bff5afb0cf2bb75035f01ebf460 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ae20f19adfa573e4f5a63b2202e4dd |
| publicationDate | 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2288226-C2 |
| titleOfInvention | Derivatives of 4-aminobenzopyrane |
| abstract | FIELD: organic chemistry, medicine, pharmacy. n SUBSTANCE: invention relates to novel derivatives of benzopyrane of the formula (I): wherein each R 1 and R 2 represent independently (C 1 -C 6 )-alkyl group; R 3 represents hydroxyl group; R 4 represents hydrogen atom; R 6 represents hydrogen atom; R 7 represents hydrogen atom; X is absent or represents C=O; R 8 represents hydrogen atom or (C 1 -C 6 )-alkyl group; R 9 represents nitro-group; Y represents (C 3 -C 8 )-alkylene group, group -(CH 2 ) m -CR 11 R 12 -(CH 2 ) n - wherein M and n are equal and each means independently 0, 1, 2, 3 or 4; m + n = 2 or above; when m = 0 then each R 11 and R 12 represents independently (C 1 -C 6 )-alkyl group or hydroxyl group; Y represents group -(CH 2 ) o -O-(CH 2 ) p - wherein o and p are equal and each means independently 2, 3 or 4; R 5 represents hydrogen atom, amino-group, (C 1 -C 6 )-alkoxy-group, (C 3 -C 8 )-cycloalkyl group, (C 1 -C 6 )-alkylthio-group, (C 1 -C 6 )-alkylamino-group, di-(C 1 -C 6 )-alkylamino-group, (C 1 -C 6 )-alkoxycarbonylamino-group, and to their pharmaceutically acceptable salts, and to an anti-arrhythmic agent. n EFFECT: valuable medicinal properties of derivatives. n 7 cl, 1 tbl, 9 ex |
| priorityDate | 2001-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.